The prospects for a human malaria vaccine

James F. Young, George Poste

Research output: Contribution to journalReview articlepeer-review


Traditional methods of controlling malaria with insecticides and parasiticides have been inadequate. The use of hybridoma and recombinant DNA technologies to study the malaria parasite has permitted the identification of several antigens which may elicit protective immune responses. Clincial trials have begun to evaluate the merits of these molecules as vaccine candidates. It is hoped that their large scale production in genetically engineered hosts will result in the development of an effective vaccine.

Original languageEnglish (US)
Pages (from-to)63-68
Number of pages6
JournalTrends in Biotechnology
Issue number3
StatePublished - Mar 1988
Externally publishedYes

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering


Dive into the research topics of 'The prospects for a human malaria vaccine'. Together they form a unique fingerprint.

Cite this